The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 04, 2024
Filed:
May. 31, 2019
Applicant:
Eisai R&d Management Co., Ltd., Tokyo, JP;
Inventors:
Ermira Pazolli, Wayland, MA (US);
Silvia Buonamici, Boston, MA (US);
James Palacino, Wellesley, MA (US);
Michael Seiler, Belmont, MA (US);
Ping Zhu, Acton, MA (US);
Evan Barry, Milford, MA (US);
Lihua Yu, Acton, MA (US);
Assignee:
EISAI R&D MANAGEMENT CO., LTD., Tokyo, JP;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 35/17 (2015.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 35/17 (2013.01); A61K 38/191 (2013.01); A61K 38/2013 (2013.01); A61K 38/2066 (2013.01); A61K 38/208 (2013.01); A61K 38/2086 (2013.01); A61K 38/217 (2013.01); A61K 39/0011 (2013.01); A61K 39/39 (2013.01); A61K 39/3955 (2013.01); A61K 47/6803 (2017.08); A61K 2039/6031 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6056 (2013.01); A61K 2039/6081 (2013.01);
Abstract
This disclosure relates to methods for the treatment of neoplastic disorders by administering Compound 1, or a pharmaceutically acceptably salt thereof, on its own and/or as part of a conjugate or composition, and inducing production of at least one neoantigen.